loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Poly DL Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    View Presentation

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Nomisma Healthcare

    filter clear-filterReset all filters

    PharmaCompass

    01

    Nomisma Healthcare

    PDLLA

    arrow
    Fi Europe 2024
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PDLLA

    Application : Controlled & Modified Release

    Excipient Details : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PDLLA

    Applications : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth